.Attribute Medication, Released online: 03 September 2024 doi:10.1038/ s41591-024-03223-zThis Standpoint asks for incorporation of clients along with MASLD and dimension of liver results in cardio-- kidney-- metabolic tests, when data recommend mechanistically plausible advantages as well as professional protection-- and also lays out factors to consider for trial layout and regulative approval.